Evidence map›Paper›PMID 34483846›Full record

ArticleFrontiers in cellular neuroscience2021

Inhibition of Fatty Acid Synthesis Aggravates Brain Injury, Reduces Blood-Brain Barrier Integrity and Impairs Neurological Recovery in a Murine Stroke Model.

Lisa Janssen, Xiaoyu Ai, Xuan Zheng, Wei Wei, Ahmet B Caglayan, Ertugrul Kilic, Ya-Chao Wang, Dirk M Hermann, Vivek Venkataramani, Mathias Bähr and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Lisa JanssenDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Xiaoyu AiDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Xuan ZhengDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Wei WeiDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Ahmet B CaglayanRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey.
Ertugrul KilicRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey.
Ya-Chao WangThe Institute of Translational Medicine, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China.
Dirk M HermannDepartment of Neurology, University of Duisburg-Essen, Essen, Germany.
Vivek VenkataramaniDepartment of Medicine II, University Hospital Frankfurt, Frankfurt, Germany.
Mathias BährDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Thorsten R DoeppnerDepartment of Neurology, University Medical Center Göttingen, Göttingen, Germany.
Universitätsmedizin Göttingen · DEIstanbul Medipol University · TRShenzhen Second People's Hospital · CNUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibition of fatty acid synthesis (FAS) stimulates tumor cell death and reduces angiogenesis. When SH-SY5Y cells or primary neurons are exposed to hypoxia only, inhibition of FAS yields significantly enhanced cell injury. The pathophysiology of stroke, however, is not only restricted to hypoxia but also includes reoxygenation injury. Hence, an oxygen-glucose-deprivation (OGD) model with subsequent reoxygenation in both SH-SY5Y cells and primary neurons as well as a murine stroke model were used herein in order to study the role of FAS inhibition and its underlying mechanisms. SH-SY5Y cells and cortical neurons exposed to 10 h of OGD and 24 h of reoxygenation displayed prominent cell death when treated with the Acetyl-CoA carboxylase inhibitor TOFA or the fatty acid synthase inhibitor cerulenin. Such FAS inhibition reduced the reduction potential of these cells, as indicated by increased NADH

Indexed as

blood-brain barriercerebral ischemiafatty acid synthesishypoxianeuroprotectionreduction potential

Identifiers

PMID34483846
PMCPMC8415573
OpenAlexW3194957885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.